The role of cerebrospinal fluid and other biomarker modalities in the Alzheimer's disease diagnostic revolution

被引：21
|
作者：
Schindler, Suzanne E. [1 ,2 ]
Atri, Alireza [3 ,4 ,5 ]
机构：
[1] Washington Univ St Louis, Dept Neurol, St Louis, MO 63130 USA
[2] Charles F & Joanne Knight Alzheimer Dis Res Ctr, St Louis, MO 63130 USA
[3] Banner Hlth, Banner Sun Hlth Res Inst, Sun City, AZ USA
[4] Brigham & Womens Hosp, Ctr Brain Mind Med, Dept Neurol, Boston, MA USA
[5] Harvard Med Sch, Boston, MA USA
来源：
NATURE AGING | 2023年 / 3卷 / 05期
关键词：
TAU;
D O I：
10.1038/s43587-023-00400-6
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
A major transformation in dementia diagnosis and care appears imminent and will depend on three major types of biomarkers: molecular imaging, blood-based biomarkers and cerebrospinal fluid biomarkers. Each modality has unique strengths and limitations that suggest its optimal uses in research, clinical trials and clinical diagnosis.
引用
收藏
页码：460 / 462
页数：3
相关论文
共 50 条
  • [31] Comparison of cerebrospinal fluid, plasma and neuroimaging biomarker utility in Alzheimer's disease
    Meeker, Karin L.
    Luckett, Patrick H.
    Barthelemy, Nicolas R.
    Hobbs, Diana A.
    Chen, Charles
    Bollinger, James
    Ovod, Vitaliy
    Flores, Shaney
    Keefe, Sarah
    Henson, Rachel L.
    Herries, Elizabeth M.
    Mcdade, Eric
    Hassenstab, Jason J.
    Xiong, Chengjie
    Cruchaga, Carlos
    Benzinger, Tammie L. S.
    Holtzman, David M.
    Schindler, Suzanne E.
    Bateman, Randall J.
    Morris, John C.
    Gordon, Brian A.
    Ances, Beau M.
    BRAIN COMMUNICATIONS, 2024, 6 (02)
  • [32] Cerebrospinal fluid biomarker profiling of diverse pathophysiological domains in Alzheimer's disease
    Trombetta, Bianca A.
    Wu, Chao-Yi
    Kuo, Evan
    de Geus, Matthijs B.
    Dodge, Hiroko H.
    Carlyle, Becky C.
    Kivisakk, Pia
    Arnold, Steven E.
    ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS, 2024, 10 (01)
  • [33] The Role of Cerebrospinal Fluid Biomarkers in the Evolution of Diagnostic Criteria in Alzheimer's Disease: Shortcomings in Prodromal Diagnosis
    Szalardy, Levente
    Zadori, Denes
    Klivenyi, Peter
    Vecsei, Laszlo
    JOURNAL OF ALZHEIMERS DISEASE, 2016, 53 (02) : 373 - 392
  • [34] Appropriateness of Applying Cerebrospinal Fluid Biomarker Cutoffs from Alzheimer's Disease to Parkinson's Disease
    Weinshel, Sarah
    Irwin, David J.
    Zhang, Panpan
    Weintraub, Daniel
    Shaw, Leslie M.
    Siderowf, Andrew
    Xie, Sharon X.
    JOURNAL OF PARKINSONS DISEASE, 2022, 12 (04) : 1155 - 1167
  • [35] Different cerebrospinal fluid biomarker patterns in dementia patients with cerebrovascular disease and Alzheimer's disease
    Bjerke, M.
    Jonsson, M.
    Zetterberg, H.
    Blennow, K.
    Schmidt, R.
    Wallin, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 103 - 103
  • [36] Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease
    Ishiguro, K
    Ohno, H
    Arai, H
    Yamaguchi, H
    Urakami, K
    Park, JM
    Sato, K
    Kohno, H
    Imahori, K
    NEUROSCIENCE LETTERS, 1999, 270 (02) : 91 - 94
  • [37] Cerebrospinal fluid tau protein as a potential diagnostic marker in Alzheimer's disease
    Arai, H
    Clark, CM
    Ewbank, DC
    Takase, S
    Higuchi, S
    Miura, M
    Seki, H
    Higuchi, M
    Matsui, T
    Lee, VMY
    Trojanowski, JQ
    Sasaki, H
    NEUROBIOLOGY OF AGING, 1998, 19 (02) : 125 - 126
  • [38] Fluorescence burst analysis of cerebrospinal fluid as a diagnostic tool for Alzheimer's disease
    Bark, N
    Rigler, R
    Terenius, L
    Tjernberg, L
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S377 - S377
  • [39] A protein panel in cerebrospinal fluid for diagnostic and predictive assessment of Alzheimer's disease
    Haque, Rafi
    Watson, Caroline M.
    Liu, Jiaqi
    Carter, E. Kathleen
    Duong, Duc M.
    Lah, James J.
    Wingo, Aliza P.
    Roberts, Blaine R.
    Johnson, Erik C. B.
    Saykin, Andrew J.
    Shaw, Leslie M.
    Seyfried, Nicholas T.
    Wingo, Thomas S.
    Levey, Allan I.
    SCIENCE TRANSLATIONAL MEDICINE, 2023, 15 (712)
  • [40] Preanalytical Variables and Alzheimer Disease Biomarker Concentrations in Cerebrospinal Fluid
    Florkowski, Christopher M.
    CLINICAL CHEMISTRY, 2015, 61 (05) : 686 - 688
12345